decisionhealth Newsletters, Coder Pink Sheets - 2004 Issue 1 (January)
Good news/Bad news: Fee fix means more for procedures, Drug reform means fewer $$ for prostate cancer drugs
Subscribe or sign in to view the full article.
Article Overview
This article explains Medicare payment updates tied to a late-year fee schedule fix and related drug reimbursement reform. It is relevant to physicians, billers, coders, and practice managers who follow Medicare policy changes affecting procedure payments and office-based injectable drug reimbursement. The discussion covers general fee schedule impacts, relative value updates, and the shift in Medicare payment methodology for certain prostate cancer drugs, along with practical implications for different practice settings.
Why This Topic Matters
The article matters because it highlights how Medicare policy changes can raise reimbursement for some procedures while reducing payment for commonly used office-administered drugs. Practices that bill Medicare need to understand the broad scope of the changes and anticipate operational and financial effects.
What You Will Learn
- How a Medicare fee schedule fix affected 2004 payment levels for certain procedures
- How Medicare drug reimbursement changes affected office-administered prostate cancer medications
- What broader payment methodology changes were being phased in for future years
- How payment policy changes can affect different practice sizes and office workflows
Who Should Read This
- Physicians
- Medical coders
- Medical billers
- Practice managers
- Urology practices
- Healthcare finance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com